The European School of Multimodality Imaging & Therapy (ESMIT)

Parathyroid Imaging (Self-paced)
2025-06-01 00:00 - 23:59 (Europe/Vienna) | Online
UEMS EACCME has granted the accreditation of 2.5 CME credits for this event.

This self-paced online course will offer a comprehensive exploration of the anatomy, physiology, and diagnostic tools related to parathyroid glands disorders. The course will cover a range of topics, including the regulation of parathyroid hormone (PTH) secretion and his mechanisms of action, etiology, clinical manifestations, and notably the diagnostic approaches ( laboratory and imaging), and treatment modalities especially concerning hyperparathyroidism.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

Attendees will gain insights into structure and function of the parathyroid glands, earning about etiology, clinical manifestations, diagnostic approaches focused on nuclear medicine and radiological techniques and treatment modalities of hyperparathyroidism. Through lectures, and case studies, participants will acquire the knowledge and skills necessary to diagnose and manage parathyroid disorders.

Target audience

This course is designed for Nuclear Medicine Physicians, Endocrinologists and Radiologists.

ProgrammeClick to see the Preliminary Programme. Please note, that it may be subject to change at any time. Programme

Faculty

Luca GiovanellaZurich, Switzerland

Murat TuncelAnkara, Türkiye

Michael KreisslMagdeburg, Germany

Petra PetranovicZagreb, Croatia

Registration Details

Registration Fee

Course Fee Free

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired course under ‘Online Courses’

Enjoy!Once enrolled, you get full access to the course contents on the ESMIT eLearning platform

Event Overview

AD-LEARN mini-course for Techs and Nurses: The Value and Challenges of Brain SPECT in PET in Neurocognitive Disorders
2025-05-20 13:00 - 2025-05-21 17:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
The course is designed for Technologists and Nurses to enhance their expertise in applying radiopharmaceuticals for AD and MCI diagnosis in nuclear medicine. Participants will learn radiation protection principles, radiolabelling procedures, and waste management. The program also covers novel PET radiotracers for molecular diagnosis of neurocognitive disorders. Additionally, the course addresses patient and caregiver management and the role of Technologists in operating SPECT and PET equipment for AD and MCI imaging. Led by European experts, the interactive sessions will allow participants to engage in discussions and ask questions, fostering a deeper understanding of the subject.

Register now for the VIRTUAL EXPERIENCEIn case you cannot join us in Vienna, here is your chance to follow the course live online! Register now

Learning Objectives

To gain knowledge about the methods and principles of radiolabelling and waste management with a special focus on radiation protection

To become educated in terms of radiotracers used in neurocognitive disorders diagnostic management

To learn the radiolabelling procedures’ adverse events basics and errors’ prevention

To be informed about the principles and importance of appropriate cooperation between medical professional, patient and their caregiver before, during and after SPECT and PET neurocognitive diseases’ imaging

To understand the roles and responsibilities of Technologists and Nurses in the nuclear medicine neurocognitive diseases’ diagnostic management

To improve the skills in terms of the interdisciplinary medical team collaboration focusing on Technologists/Nurses and other medical specialists’ cooperation.

Target Audience

Technologists and Nurses

ProgrammeView the Programme

Faculty

Markus KӧhnerSpeakerErlangen, Germany

Daniela FonsecaSpeakerLondon, UK

Valentina MautoneSpeakerMeldola, Italy

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee Registration for this course is free, but we will charge a €100 fee to book your seat, which will be reimbursed upon attendance

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

AD-LEARN Mini-course for Residents: How to Start Reading Brain Scans in Neurocognitive Disorders?
2025-05-19 08:00 - 2025-05-20 12:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
The course aims to provide the participants with basic knowledge regarding nuclear and molecular medical imaging in the neurological field. In particular, cerebral SPET and PET will be addressed.

Register now for the VIRTUAL EXPERIENCEIn case you cannot join us in Vienna, here is your chance to follow the course live online! Register now

Learning Objectives

Clinical introduction and positioning where imaging is indicated: The aim is to understand the main indications of cerebral SPET and PET methods and the patient’s preparation before the examination.

Primer course: how to read a brain SPECT study: the aim is to understand how to acquire, reconstruct, format and read a perfusion and receptorial brain SPET and SPET/CT. The main clinical patterns will also be presented.

Primer course: how to read an FDG-PET brain study: the aim is to understand how to acquire, reconstruct, format and read an FDG brain PET/CT. The main clinical patterns will also be presented.

Peer-learning with tips and tricks, and case presentation: the aim is to understand how to acquire, reconstruct, format and read a perfusion and receptorial brain SPET and SPET/CT. The main clinical patterns will also be presented.

Target Audience

Nuclear medicine specialists with little or no experience in reading SPET and PET neurological imaging.

ProgrammeView the Programme

Faculty

Igor YakushevSpeakerMunich, Germany

Stelvio SestiniSpeakerPrato, Italy

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee Registration for this course is free, but we will charge a €100 fee to book your seat, which will be reimbursed upon attendance

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

CANCELLED: Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease
2025-05-15 09:00 - 2025-05-16 16:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
More information coming soon

Register nowThis course is cancelled.

Learning Objectives

Target Audience

More information coming soon

More information coming soon

ProgrammeComing soon View the Programme

Faculty

Speaker

Speaker

Speaker

Speaker

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks on each Course Day

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Introducing Dosimetry in the Clinical Setting
2025-05-09 13:30 - 14:30
This course presents and discusses the requirements and methods to enable and perform personalized dosimetry in nuclear medicine therapy.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

The aim of this course is to provide tools and methods to implement personalized dosimetry in a clinical setup.

Target Audience

Nuclear medicine clinicians and medical physicists

Suggested Readings

“EANM enabling guide: how to improve the accessibility of clinical dosimetry.” Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry

Click Here

Faculty

Jonathan GearSpeaker

Pablo Mínguez GabiñaSpeaker

Eivor HernesSpeaker

Silvano GnesinModerator

Event Overview

ESMO-EANM Course on Diagnostic and Therapeutic Applications of Nuclear Medicine in Oncology
2025-05-06 00:00 - 2025-05-07 23:59
Learning Objectives

To get an updated analysis of the diagnostic and therapeutic applications of nuclear medicine in oncology

To provide a knowledge of principles of both nuclear medicine modalities and systemic oncologic therapies in advanced trainees and specialists in oncology and nuclear medicine

To provide an educational framework for in-depth analysis of the combined diagnostic/therapeutic strategies (theranostics) in oncology and scientific interaction between oncology and nuclear medicine experts

To foster interdisciplinary exchange and collaboration in both nuclear medicine imaging and nuclear medicine treatment applications

Find out moreMore information about the course, including registration, can be found on the ESMO website Find out more

Gynaecological Malignancies
2025-05-01 00:00 - 23:59 | Online
UEMS EACCME has granted the accreditation of 3 CME credits for this event.

The present course aims to describe the current status, in terms of diagnosis and therapy for gynecological cancers. All the gynecological malignancies (i.e., ovary cancer, endometrial cancer, cervical and vaginal cancer) will be evaluated from the oncological and from diagnostic point of view, with a major emphasis on the role of nuclear medicine, both in diagnosis and therapy.

The speakers are specialists in oncology, radiology and nuclear medicine with a clinical experience in gynecological cancer and will provide some examples that can be found in every day clinical practice.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

Target Audience

Learn about the current available therapies useful for the treatment of gynecological cancer;

Understand the correct diagnostic flow-chart for the management of patients affected by gynecological cancer;

Describe the potential future perspectives in nuclear medicine to face gynecological cancer, from a diagnostic and therapeutical point of view

Oncologists, Radiologists, Nuclear Medicine Physicians, Technicians, Endocrinologists, Gynecologists

ProgrammeClick to see the full event programme. View the Programme

Faculty

Cristina FerrariNuclear Medicine, Italy

Giulia TascaOncology, Italy

Teresa Margarida CunhaRadiology, Portugal

Helen Clare AddleyRadiology, United Kingdom

Desiree Deandreis Nuclear Medicine, France

Ora Israel Nuclear Medicine, Israel

Ozgul EckmekciogluNuclear Medicine, Turkeye

Henrique NabaisGynaecology, Portugal

Monica PiresGynaecology, Portugal

Registration Details

Registration FeeMode of Payment

Course Fee € 300.- + Local VAT Rate

Credit card via the ESMIT eLearning store

Cheques will not be accepted.

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired course under ‘Online Courses’

Enjoy!Once paid, you get full access to the course contents on the ESMIT eLearning platform

Event Overview

Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging (pre-recorded)
2025-04-25 13:30 - 14:30
more information coming soon

Register nowEnrol in the live webinar now for free! Register now

Faculty

Speaker

Speaker

Speaker

Event Overview

Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging
2025-04-25 00:00 - 2026-04-25 23:59 | Online
Breast cancer remains the most frequently diagnosed cancer and the leading cause of cancer-related death in women worldwide. Despite significant advancements in imaging and treatment, clinical practice remains heterogeneous across institutions and disciplines. Molecular imaging has a pivotal role in breast cancer care, from diagnosis to recurrence assessment. To address these discrepancies and define the future direction of imaging in breast cancer, the European Association of Nuclear Medicine (EANM) devoted its 6th Focus Meeting to this topic, under the following motto “Shaping the Future of Breast Cancer Care with Molecular Imaging”.

The aims of this project were:

To define the role of imaging in breast cancer, particularly the utility of nuclear medicine techniques in different clinical settings (including initial systemic staging, assessment of response to therapy, and detection of recurrence).

To reach a multidisciplinary consensus on the current state of the art in nuclear medicine imaging in breast cancer.

To generate expert recommendations on how best to guide professionals in their clinical decisions, beyond the existing guidelines.

To identify knowledge gaps and topics with lack of scientific evidence for potential future studies.

The recordings in this course are sponsored by Novartis.

Register nowEnrol in the online course now for free! Register now

Faculty

Isabel T. RubioSpeaker

Frederique Penault LlorcaSpeaker

Thiemo van NijnattenSpeaker

Elizabeth DibbleSpeaker

Tessa BuckleSpeaker

Katja Pinker DomenigSpeaker

Sofia Carrilho-VazSpeaker

Martina Bašić-KoretićSpeaker

David GroheuxSpeaker

Gary UlanerSpeaker

Geraldine GebhartSpeaker

Wolfgang WeberSpeaker

Valeria RomeoSpeaker

Alessandra GennariSpeaker

Karolien GoffinSpeaker

Nadia HarbeckSpeaker

Pascal BaltzerSpeaker

Michel van KruchtenSpeaker

Gary Cook Speaker

Paola Anna ErbaSpeaker

Joana M RibeiroSpeaker

Carolien SchröderSpeaker

Ritse MannSpeaker

Philipp BackhausSpeaker

Malene Gubbe Hildebrand Speaker

Fatima CardosoSpeaker

Antoinette AttardSpeaker

Francesco SchnettiniSpeaker

Sofia RiveraSpeaker

Event Overview

Treatment of Metastatic Bone Pain Using Bone-Seeking Agents
2025-04-10 09:00 - 2025-04-11 16:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
Internal radiotherapy with bone-seeking agents is effective in delivering high doses of radiation to widespread metastatic bone lesions and may limit the radiation absorbed dose to healthy tissue. Beta emitter have long been preferred agents for bone pain palliation. The approval of 223Ra and data showing a prolonged survival with alpha emitter are favored in bone pain palliation. Unfortunately, we do not have good data on the survival after treatment with beta emitters. In the face-to-face course we will discuss the pathophysiology of bone pain to understand the principle of therapeutic effect of bone seeking agents. Dosimetry is essential to increase the dose to the tumor by limiting of severe side effects. All the focus is on the alpha emitters only, based on the poor data about survival data for the beta emitters. The future of therapy in Nuclear Medicine is the combination with other agents to improve the therapeutic effect, e.g. chemotherapy, immunotherapy or anti-androgen therapy.

Register nowClick on the button to sign up for the course. Register now

Learning Objectives

Pathophysiology and medical treatment of bone pain

Pro/con alpha/beta emitters

Performing of dosimetry

Combination treatment to improve the therapeutic effect

Target Audience

Nuclear medicine physician, junior or senior, with an interest in treatment

ProgrammeView the Programme

Faculty

Knut LiepeSpeakerFrankfurt (Oder), Germany

Tatiana LouroSpeakerLisbon, Portugal

Giulia SantoSpeakerCatanzaro, Italy

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Radioiodine-Refractory Thyroid Cancer - Is it Time to Change the Definition in the Light of Novel Redifferentiation Therapies?
2025-04-04 13:30 - 14:30
This webinar explores the perspectives on radiorefractory thyroid cancer through two presentations. In the first talk the speaker challenges current diagnostic frameworks and proposes a new vision that better reflects the evolving understanding of refractory thyroid cancer. The second presentation offers a comprehensive review of emerging approaches to restore iodine avidity in radiorefractory thyroid cancer, highlighting recent clinical trials, molecular targeting techniques, and potential promising combination therapies.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

To evaluate the current definition of radiorefractory thyroid cancer and identify its limitations in clinical practice

To learn new insights for radiorefractory thyroid cancer definition and their potential impact on treatment decisions

To learn current evidence-based redifferentiation strategies for restoring iodine avidity in radiorefractory thyroid cancer

To improve knowledge of redifferentiation mechanisms to develop personalized treatment plans for patients with radiorefractory thyroid cancer

Target Audience

Nuclear Medicine physicians, Endocrinologist, Oncologist

Faculty

Petra PetranovicSpeaker

Michael KreisslSpeaker

Luca GiovanellaModerator

Event Overview

Theranostic Training: Practical and Methodological Concepts
2025-03-28 13:30 - 14:30
This webinar aims to introduce the concept of theranostics and provide an overview of its potential. Participants will gain an understanding of how our technological competencies contribute to and enhance theranostic processes, and how we can leverage these strengths in practice.

Please note that the webinar will be recorded, and the recording will be available a few days after the session is over. You can find the recording on the ESMIT E-learning platform, under the webinar title. A handout of the presentation materials will also be available on the platform.

Register nowEnroll in the live webinar now for free! Register now

Learning Objectives

Attendees will understand the concept of theranostics and its significance in modern healthcare.

Attendees will explore the foundational technologies behind theranostics and learn how departments can be organized to integrate theranostic procedures.

Attendees will gain insights into the perspectives of physicians and technologists on theranostics and how these disciplines collaborate to deliver optimal patient outcomes.

Target Audience

Technologists, Nurses, Physicists

Faculty

Riccardo LaudicellaSpeaker

Daniela FonsecaSpeaker

Angelo CardosoModerator

Conrad-Amadeus VoltinModerator

Event Overview

Cardiac Amyloidosis Imaging: History, Status Quo and Outlook
2025-03-20 09:00 - 2025-03-21 16:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
This course provides a comprehensive overview of the multimodality diagnosis of cardiac amyloidosis. Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. Imaging modalities will include a focus on echocardiography, cardiac MRI, SPECT, and PET, with discussion of the various tracers available. It will be elaborated when which of the different imaging modalities can be used appropriately and multimodality concepts will also be discussed. The course content will be developed using numerous case examples. Furthermore, the course participants should solve cases independently and discuss them with the other course participants.

Register nowRegistrations are closed. Please contact us at esmit@eanm.org if you are still interested in signing up for the course.

Learning Objectives

Gain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.

Gain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.

Become familiar with the various imaging modalities available for the diagnosis of cardiac amyloidosis.

To learn the appropriate use of diagnostic options in cardiac amyloidosis (keyword: diagnostic algorithm).

To independently make the correct diagnosis of cardiac amyloidosis on the basis of case studies.

To learn the possibilities of quantification of SPECT and PET.

Target Audience

Nuclear physicians, cardiologists, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics.

ProgrammeView the Programme

Faculty

Stephan NekollaSpeakerMunich, Germany

Raffaella CalabrettaSpeakerVienna, Austria

Carmela NappiSpeakerNaples,Italy

Dietrich BeitzkeSpeakerVienna,Austria

Michael PoledniczekSpeakerVienna,Austria

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Advantages of Long-Axial Field-of-View PET in Inflammation and Infection Imaging
2025-03-07 13:30 - 14:30
Long axial field of view (LAFOV) PET/CT is the latest development in PET instrumentation. This webinar will provide an overview of the clinical opportunities and applications of LAFOV PET in inflammation and infection imaging.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Attendees will be able to describe the main advantages of LAFOV PET in patients with inflammatory and infectious disorders.

Attendees will be able to understand how the increased sensitivity of LAFOV PET/CT allows for faster scanning and/or an important reduction in injected activity, and how it also enables dynamic whole-body PET imaging, studying molecular interactions between organ systems and even delayed imaging.

Attendees will be able to see that ultrafast imaging can facilitate imaging of new patient groups such as critically ill patients, patients admitted to intensive care with persistent infection or children without sedation.

Target Audience

Nuclear Medicine Physicians, Residents, Technologists

Faculty

Joyce van SluisSpeaker

Lars GormsenSpeaker

Andor GlaudemansSpeaker

Oliver GheysensModerator

Event Overview

Fundamentals of Research in Imaging and Theranostics Part 2
2025-03-01 08:00 - 2027-03-30 17:00
UEMS EACCME has granted the accreditation of 4.5 CME credits for this event.

This online course is part of a longer line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation, as well as the design, conductance and reporting of clinical research trials, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

For phase I/II clinical studies with radiopharmaceuticals to understand:

The principles of technical realisation of the study including assessment of safety of investigational medicinal product

The statistical considerations, including the estimation of number of subjects to be enrolled

The regulatory requirements for performing clinical studies with radiopharmaceutical with special focus on diagnostic radiopharmaceuticals and to summarise the particularities of these studies

The ethical and medical considerations in common and vulnerable populations

The principles of preparing the clinical study protocol

The objectives, endpoints and outcome measures

The principles of patient selection, inclusion and non-inclusion criteria

The principles of establishment of the standard of truth, the role of the comparator, superiority/non-inferiority/equivalence(?) studies) & practical examples

Target Audience

Personnel involved in designing and/or performing phase I/II clinical research with diagnostic radiopharmaceuticals (e.g. nuclear medicine physicians, pharmacists, physicists, nurses, technologist, administrative staff).

Personnel involved in assessment of the ethical, medical and methodologic aspects of phase I/II research protocols with diagnostic radiopharmaceuticals.

All professionals interested in phase I/II clinical research with diagnostic radiopharmaceuticals

Faculty

Chiara GranaSpeaker

Bart de KeizerSpeaker

Caroline StokkeSpeaker

Jean-Noel TalbotSpeaker

Luisa Roldao PereiraSpeaker

John Andrei IagaruSpeaker

Sona BalogovaSpeaker

Surgery in Neuroendocrine Neoplasms (NENs)
2025-02-21 13:30 - 14:30
Neuroendocrine tumours (NETs) are a rare but clinically significant group of malignancies arising from neuroendocrine cells, often presenting in the gastrointestinal tract or lungs. While NETs account for a small fraction of overall cancer cases, their incidence is steadily rising. Radioguided surgery has emerged as a highly effective approach for treating NETs, particularly in cases of primary tumours or oligometastatic disease, where nuclear medicine imaging precisely localizes the lesions and surgical resection is feasible.

This session will explore the current landscape of radioguided surgery, with a specific focus onneuroendocrine tumour applications. We will begin by reviewing the latest tracers and instrumentation employed in radioguided procedures, discussing their mechanisms, advantages, and limitations. Following this, we will delve into the clinical integration of these tracers and devices, examining their role in the routine surgical workflow for NETs. By highlighting the practical implications and clinical outcomes, this session aims to provide attendees with actionable insights into advancing care for patients with neuroendocrine tumours.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Attendees will be able to describe the latest advancements in radiotracers and surgical instrumentation for radioguided neuroendocrine tumour surgery, including their mechanisms of action and clinical benefits.

Attendees will be able to evaluate the indications for radioguided surgery in neuroendocrine tumours, such as primary tumours and oligometastatic disease, based on pre-operative nuclear medicine imaging.

Attendees will be able to outline the steps required to integrate novel radiotracers and devices into the clinical workflow, from surgical planning to intraoperative application, with a focus on improving patient outcomes.

Target Audience

Surgical oncologists, nuclear medical physicians, medical physicists

Faculty

Thomas WendlerModerator

Pedro Fragoso Costa Speaker

John Orozco CortesSpeaker

Event Overview

Artificial Intelligence in Nuclear Medicine – Current Status and Future Perspective
2025-02-13 09:00 - 2025-02-14 16:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
Artificial intelligence with the development of deep learning has found numerous applications in the medical field over the past few years, including more specifically that of medical imaging. This includes most areas governing the medical imaging process from detector signal processing to image formation and subsequent image processing. The activity of deep learning spans from the more fundamental aspects such as image reconstruction and associated corrections to more clinical applications driven developments such as that of imaging biomarkers and their usage in patient classification for diagnosis or therapy response monitoring. Although most of these developments are still part of active research, certain software solutions are slowly finding their way in mainstream clinical reality with multiple clinical evaluation studies currently underway. The course will cover an overview of the main developments of deep learning in the different areas of image formation, processing and associated clinical applications within the field of nuclear medical imaging and associated multimodalities. Certain examples of potential clinical interest will be covered in each of the above-mentioned areas.

Register nowRegistration now closed. For last minute interest, please contact esmit@eanm.org

Learning Objectives

Understand the basic principles of deep learning algorithm development

Learn the latest developments in the use of deep learning for image reconstruction in nuclear and multimodality imaging

Learn the latest developments in the use of deep learning for image corrections (attenuation, scatter, etc) in nuclear and multimodality imaging

Learn the latest developments in the use of deep learning for image processing (eg. segmentation, biomarkers) in nuclear and multimodality imaging

Learn the latest developments in the use of deep learning for potential clinical applications (low dose imaging, dosimetry, diagnosis, predictive and prognostic modeling) in nuclear and multimodality imaging

Target Audience

Medical doctors (nuclear medicine, radiology), Medical Physicists, Technologists

ProgrammeView the preliminary programme. Please note it is subject to change. View the Programme

Faculty

Stephan NekollaSpeaker

Martina SolliniSpeaker

Dimitris VisvikisSpeaker

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks on each Course Day

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Bone Scan Beyond Oncological Disease
2025-02-07 13:30 - 14:30
The webinar primarily focuses on the clinical value and implementation of early phase SPECT-CT in non-oncological settings, emphasizing its advantages over traditional planar imaging and late-phase bone scans. It highlights the diagnostic enhancement of early-phase imaging for inflammatory conditions, pain assessment, and soft-tissue evaluation.

New treatment options for cardiac amyloidosis are increasing interest in early diagnosis of the disease. DPD scan is an excellent and non-invasive diagnostic modality in this diagnosis, but detailed local, whole body and SPECT/CT including calculation of different ratios are necessary for an accurate diagnosis. The presentation showed the performance of the examination, clinical and medical letter examples.

Register nowEnrol in the live webinar now for free! Register now

Faculty

Jules Zhang-YinSpeakerArlon, Belgium

Knut LiepeSpeakerFrankfurt (Oder), Germany

Event Overview

Algorithms for Dementia Imaging
2024-12-12 09:00 - 2024-12-13 12:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
UEMS EACCME has granted the accreditation of 7 CME credits for this event.

The course will offer a comprehensive overview of basic, theoretical and practical evidence-based concepts needed for a deep and thoughtful understanding of the use of [¹⁸F]FDG (FDG) Brain PET, amyloid (Amy) PET and DaT SPECT in Neurological Disorders. A brief introduction will be given on the position that each imaging technique holds in the recent European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. Then, short theoretical sessions on visual reading and semiquantification of FDG PET, Amy PET and DaT SPECT will be associated with longer hands-on sessions, for a practice-oriented learning specifically addressed to dementing disorders and neurodegenerative parkinsonian syndromes. Different approaches for semiquantification and subsequent scan reporting will be proposed and discussed. Clinical cases will be the starting point to better define the usefulness, utility and accurate reading of PET and SPECT in Alzheimer’s disease, other neurodegenerative dementias and Parkinsonian Syndrome.n coming soon

Save yourself a seatRegistration closed. For last minute registration, please email us at esmit@eanm.org Register now!

Learning Objectives

To familiarise with the neuroimaging tools available to objectively assess brain glucose metabolism, amyloid deposition and dopaminergic system integrity, and their position in recent European recommendations

To learn strengths and weaknesses of different approaches for semiquantification

To appropriately choose a semi-quantitative support for image interpretation in various conditions

The course will provide important information on the most recent developments for an improved clinical practice, of utmost importance for nuclear medicine physicians.

Target Audience

General nuclear medicine specialists, radiologists who want to update their knowledge on reading, semiquantification and reporting of FDG PET, Amy PET and DaT SPECT in terms of clinical indications, reading skills and pitfalls. The constantly evolving role of Brain PET in neurodegenerative disorders makes the track of interest also for neurologists who want to improve their knowledge of cutting-edge Neuroimaging tools.

Faculty

Valentina BertiSpeakerFlorence, Italy

Igor YakushevSpeakerMunich, Germany

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks on each Course Day

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Event Overview

Treatment of Metastatic Bone Pain Using Bone-Seeking Agents
2024-12-06 13:30 - 14:30
With the arrival of new therapeutic tracers, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of nuclear medicine among other treatment modalities (external beam therapy, medical treatment, chemotherapy).

Learning Objectives: Refresh knowledge on the pathophysiology of pain and present the opportunities and limitations of alpha and beta therapy in metastatic bone pain treatment

Save yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!

Faculty

Jules Zhang-YinModeratorArlon, Belgium

Knut LiepeSpeakerFrankfurt (Oder), Germany

Tatiana LouroSpeakerLisbon, Portugal

Registration

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE

Enjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents

Event Overview

Japanese vs. European View on Amyloid Imaging and Therapy (in collaboration with JSNM)
2024-12-02 10:00 - 11:00
The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However, due to differences in clinical processes and insurance systems in each country, the use of amyloid PET in the diagnostic tree currently varies from country to country. In Europe, CSF diagnosis is often performed first and amyloid PET is performed in selected patients. In Japan, only either CSF diagnosis or amyloid PET is covered by public insurance, so there is a trend toward performing the more expensive PET first. The use of amyloid PET in the setting of anti-AB therapy monitoring, and its exact positioning in the biomarkers flow-chart is not yet clearly defined. This webinar will present recent findings on the usefulness of amyloid PET and the differences in actual use between Europe and Japan.

Learning Objectives: tba

Save yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!

Faculty

Donatienne Van WeehaegheModerator

Prof. Dr. med. Dr. biol. hum. Matthias Brendel, MHBASpeakerDepartment leadBoard certified Nuclear Medicine physician Research lead for neurodegenerative disorders LMU Klinikum Department of Nuclear MedicineUniversity Hospital of Munich

Dr. Kenji IshiiSpeakerDirectorDiagnostic Neuroimaging ResearchTokyo Metropolitan Institute for Geriatrics and GerontologyTokyo, Japan

Registration

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE

Enjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents

Event Overview

Challenges of Zr89 Imaging
2024-11-22 13:30 - 14:30
While PET imaging with radionuclides such as F18 and Ga68 have proven to provide high quality diagnostic imaging, imaging with other radionuclides can be more challenging. Zr-89 is one such radionuclide. Although Zr-89 has advantageous labelling properties for cell imaging and the imaging of monoclonal antibodies, the radionuclide is non-ideal imaging qualities mostly due to its low dosage, and also brings with it radiation safety challenges. This webinar will present both sides of Zr-89 imaging, the clinically relevant opportunities for the radionuclide, and the quantification challenges, handling and the safety aspects of Zr-89.

Learning Objectives: The aim of this webinar is to show the potential and the challenges of Zr-89 imaging.

Save yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!

Faculty

Floris H.P. van VeldenModeratorLeiden, Netherlands

Erik AarntzenSpeakerNijmegen, Netherlands

Marc C. HuismanSpeakerAmsterdam, Netherlands

Registration

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE

Enjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents

Event Overview

Focus on Molecular-guided Surgery
2024-11-14 08:00 - 2024-11-15 17:00 | Hospital Clínico de Barcelona, Carrer de Villarroel, 170, L'Eixample, Barcelona, 08036, Spain
An application has been submitted to the UEMS EACCME for CME accreditation.

The course has a hybrid format with on-site lectures and hands-on practical and technic sessions, It will cover the basic and some advanced and future aspects of Radioguided surgery with a focus on the technologist’s work and support the multidisciplinary team in charge of Radioguided procedures.

Save yourself a seatRegistration closed. For last-minute sign up please contact esmit@eanm.org

Target Audience

This course aims to spread information and practice to technologist, nurses, medical staff (nuclear medicine, surgeons, radiologist) in order to provide an interactive setting to share ideas and refine current and future approaches in the field of Radioguided Surgery

Learning Objectives

To Define the radioguided surgery principles, applications, methodology.

Overview the current state of the art of the radioguided surgery.

List the clinical indications of introducing radioguided surgery to the patients.

Explain the paper of a multidisciplinary team in the context of radioguided surgery.

Protocols and methodologies of conventional NM exams used in radioguided surgery

Conventional nuclear medicine in the context of radioguided surgery: best practice, radiation protection and safety, organisation and patient management.

To provide the potential benefits of new technologies like IA and future perspectives.

ProgrammeClick to see the Preliminary Programme. Please note, that it may be subject to change at any time. View the Programme

Faculty

Sergi Vidal-SicartSpeaker

Chiara Maria GranaSpeaker

Renato Valdés OlmosSpeaker

John OrozcoSpeaker

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 863.64

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks on each Course Day

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Event Overview

Artificial Intelligence in Dosimetry
2024-11-08 13:30 - 14:30
The rapid development in machine learning has generated new artificial intelligence (AI) based methods for improving dosimetry within nuclear medicine. This webinar will present the current status of AI within the dosimetry workflow for targeted radionuclide therapy. First, AI methods for reducing SPECT acquisition times, noise reduction and scatter correction will be covered. Thereafter, AI methods for organ segmentation and voxel-based dosimetry, together with AI methods for pre-therapeutically dosimetry estimate will be highlighted.

Learning Objectives: The aim of this webinar is to understand the basics of AI methodologies used for dosimetry and receive knowledge about the current status of AI applications within dosimetry for targeted radionuclide therapies.

Save yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!

Faculty

Peter BernhardtModeratorGöteborg, Sweden

Yuni Dewaraja SpeakerMichigan, USA

Johannes Tran-GiaSpeakerWürzburg, Germany

Registration

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE

Enjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents

Event Overview

Quantification of MPI
2024-09-26 09:00 - 2024-09-27 17:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
UEMS EACCME has granted the accreditation of 10,5 CME credits for this event.

This course provides a comprehensive overview of nuclear medicine imaging of coronary artery disease. General aspects, details of radiotracers utilised, examination protocols and case examples of myocardial perfusion imaging (MPI) using PET and SPECT will be discussed at the event. The focus here will be on the quantification of data (e.g. abnormality scores, myocardial blood flow, myocardial flow reserve) collected from MPI. The event will allow for both lectures and discussions and will be an interactive event. Pitfalls and regulatory aspects will be covered as well in this course.

Save yourself a seatRegistration closed. For last-minute sign up please contact esmit@eanm.org Closed

Target Audience

The target audience includes nuclear medicine physicians, cardiologists, internists and radiologists who want to deepen their knowledge in the field of imaging coronary artery disease.

Learning Objectives

Gain a deep insight into nuclear medicine imaging of coronary artery disease.

Become familiar with radiopharmaceuticals, camera systems, examination protocols and regulatory aspects.

To learn SPECT, PET image interpretation based on visual analysis and quantification.

The technique of absolute quantification of myocardial blood flow using PET or CZT cameras.

Additional value of hybrid imaging (SPECT/CT, PET/CT and PET/MRI) in CAD.

Discussion of cases, pearls and pitfalls.

ProgrammeClick to see the Preliminary Programme. Please note, that it may be subject to change at any time. View the Programme

Faculty

Stephan NekollaSpeakerTechnical University Munich, Germany

Carmela NappiSpeakerUniversity of Naples Federico II, Italy

Federico CaobelliSpeakerUniversitätsspital Bern, Switzerland

Raffaella CalabrettaSpeakerMedizinische Universität Wien, Austria

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee Breaks on each Course Day

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Event Overview

Paediatric Nuclear Medicine in Nephro-Urology
2024-09-20 13:30 - 14:30
The webinar will cover the most relevant methodological aspects of nuclear medicine techniques in paediatric nephrourology, with particular attention to the choice of the radiotracer, the correct patient preparation, and the acquisition protocol. Some typical cases will show the main points of image processing and results visualization. The clinical part will deal with hydronephrosis and hydroureteronephrosis, spacing from typical pelvicureteral junction obstruction to obstructive megaureter, and some complex malformations, such as duplex kidneys. The selected cases will pinpoint the critical clues used in interpreting and reporting the scintigraphic studies and the integration of scintigraphic data with other imaging modalities (ultrasounds, MRI, etc.) in evaluating paediatric nephrourology patients.

Learning Objectives: The aim of this course is to review the methodology and the main indications for scintigraphic studies in paediatric nephro-urology, taking into accounts the more relevant and recent international guidelines and offering various examples taken from the current clinical practice.

Suggested Readings:1. The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children2. EANM procedural recommendations for managing the paediatric patient diagnostic nuclear medicine

Save yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!

Faculty

Diego CecchinModeratorPadua, Italy

Pietro ZucchettaSpeakerPadua, Italy

Registration

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE

Enjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents

Event Overview

FDG-PET/CT in Breast Cancer
2024-09-06 13:30 - 14:30
Breast cancer is the most common cancer in women worldwide and it is still one of the leading causes of morbi-mortality, therefore being a major concern. 2-[18F]FDG PET/CT is commonly used in the clinical management of patients with breast cancer, with significant impact on clinical management. Currently, there is robust evidence supporting the usefulness of 2-[18F]FDG PET/CT in the initial staging of patients with locally advanced and metastatic breast cancer, in the early assessment of treatment response and in the early detection of recurrence. The first presentation of this webinar will summarize the recently published “Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer” which was endorsed by other relevant societies in the subject of breast cancer (ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). Updated information to support the recommendations to perform 2-[18F]FDG PET/CT in no special type breast cancer in different clinical settings will be provided. Despite no special type breast cancer presenting high 2-[18F]FDG avidity, other breast cancer subtypes seem to be better evaluated with other PET radiopharmaceuticals. Therefore, the second presentation will address the potential role of [18F]FES, [89Zr]Trastuzumab, [18F]Sodium fluoride (NaF), [18F]Fluciclovine (FACBC), [89Zr]Pembrolizumab and FAPI-ligands in breast cancer. During this webinar we want to brainstorm about the role of PET/CT in the different subtypes and clinical scenarios of patients with breast cancer. The webinar will be enriched by interactive clinical case discussion, aiming to resemble the challenges found in daily clinical practice.

Learning Objectives:

General aspects to avoid false positive and false negative findings on 2-[18F]FDG PET/CT.

Diagnostic accuracy of 2-[18F]FDG PET/CT compared to conventional imaging modalities.

Recommendations for performing 2-[18F]FDG PET/CT in the initial staging, in assessing response to therapy and in assessing recurrence.

Appropriate PET radiopharmaceuticals to better address each breast cancer subtype.

Specific characteristics, physiological biodistribution, advantages and disadvantages of PET radiopharmaceuticals used in breast cancer beyond 2-[18F]FDG.

General interpretation criteria to optimize the information provided in the final PET/CT report.

Save yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!

Faculty

Lioe-Fee de Geus-OeiModeratorLeiden, Netherlands

Sofia VazSpeakerLisbon, Portugal

Lidija AntunovicSpeakerMilan, Italy

Registration

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE

Enjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents

Event Overview

Guidelines for the Use of FDG PET/CT in Infection and Inflammation 2.0
2024-07-05 13:30 - 14:30
General overview of the EANM/SNMMI guidelines on FDG PET/CT in inflammation and infection.

Learning Objectives: The aim of this course is to summarize the major indications for FDG PET/CT in infection and inflammation, based on the updated guidelines for nuclear medicine practice provided by the EANM/SNMMI.

Save yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!

Faculty

Andor GlaudemansModeratorGroningen, Netherlands

Olivier GheysensSpeakerBrussels, Belgium

Gad AbikhzerSpeakerMontreal, Canada

Registration

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE

Enjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents

Event Overview

Role of FDG-PET in Paediatric Hodgkin and Non-Hodgkin Lymphomas
2024-06-27 09:00 - 2024-06-28 17:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
UEMS EACCME has granted the accreditation of 8 CME credits for this event.

A large oncological framework will be the topic of the first session: three lectures by a high quoted Paediatric Oncologist: epidemiology, aetiological factors, and general classification of Paediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies and prognostic considerations. The two valuable nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas: staging and therapeutic management, the importance of the imaging-based assessment, the role of Deauville classification, prognostic aspects, surveillance, and the management of recurrent/treatment resistant forms in PHL and NHL. Current state of experimental tracers research. Future perspectives: novel radiotracers, evaluation of rare entities and advanced image analysis.

Many case readings will be presented to the attendees to train them in interpreting and concluding 18FDG in the crucial assessment point into diagnostic- therapeutic PHL and NHL protocols.

Each attendee is also asked to present a personal tricky case, proposed to the experts and to the other attendees. This allows better communication among the attendees and a more interactive practical session.

Save yourself a seatThe registration is closed. For last minute interest, contact esmit@eanm.org Register now!

Target Audience

Residents, NM specialist approaching paediatric ematology-oncology

Learning Objectives

The aim of this course is initially to refresh and update clinical setting from the point of view of the pediatric Oncologist: epidemiology, aetiological factors, and general classification of Pediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies.

The two nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas and about the importance of imaging-based assessment, and the role of Deauville classification in the main forms of PHL and NHL.

The current state of experimental tracers research and future perspectives: novel radiotracers, evaluation of rare entities and advanced image analysis. Two interactive sessions with a lot of case reading to train the attendees in the evaluation, interpretation and comparison of 18FDG-PET-CT.

ProgrammeClick to view the preliminary programme View the Programme

Faculty

Marta PillonSpeakerItaly

Pinar KiratliSpeakerTürkiye

Francesco FizSpeakerItaly

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee Breaks on each Course Day

Lunch on first Course Day

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Event Overview

Cardiovascular PET-CT and PET-MR Imaging
2024-06-14 13:30 - 14:30
Patients workflows and acquisition protocols in PET/CT and PET/MR with different radiotracers for cardiovascular nuclear medicine imaging.

Learning Objectives: To learn how to manage radioactive generators 82Sr/82Rb and to acquire cardiovascular imaging in PET/CT or PET/MR and other acquisition protocols.

Save yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!

Faculty

Paolo TurcoModeratorPadua, Italy

Stephan NekollaModeratorMunich, Germany

Sylvia SchachoffSpeakerMunich, Germany

Ian ArmstrongSpeakerManchester, UK

Registration

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE

Enjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents

Event Overview
